Here are six additional notes on the report:
1. The $187 million in net sales was made up of $158 million in global spine sales and $29 million in global orthopedic sales.
2. Net sales increased 58.4 percent over the second quarter of 2022.
3. The company’s gross profit increased $33.1 million to reach $119.6 million.
4. Orthofix is predicting 2023 full-year net sales to be between $752 million and $758 million.
5. Net income for the quarter was a loss of $39.4 million compared to a positive net income of $2.5 million in the second quarter of 2022.
6. The company reported a net income of negative $100.4 million through the first two quarters of 2023.
